BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19097374)

  • 1. [Left ventricular hypertrophy in patients treated with regular hemodialyses].
    Petrović D; Stojimirović B
    Med Pregl; 2008; 61(7-8):369-74. PubMed ID: 19097374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Left ventricular hypertrophy in patients on hemodialysis: importance of anemia].
    Stojimirović B; Petrović D; Obrenović R
    Med Pregl; 2007; 60 Suppl 2():155-9. PubMed ID: 18928184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of left ventricular hypertrophy in hemodialysis patients is possible.
    Hampl H; Sternberg C; Berweck S; Lange D; Lorenz F; Pohle C; Riedel E; Gogoll L; Hennig L
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S73-96. PubMed ID: 12227731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiac troponins and left ventricular hypertrophy in hemodialysis patients].
    Petrović D; Obrenović R; Radovanović M; Stojimirović B
    Med Pregl; 2007; 60 Suppl 2():87-90. PubMed ID: 18928167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of C-reactive protein with echocardiographic parameters of hypertrophic and ischemic heart disease in patients on regular hemodialyses].
    Petrović D; Obrenović R; Poskurica M; Stojimirović B
    Med Pregl; 2007; 60 Suppl 2():160-4. PubMed ID: 18928185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
    Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
    Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidirectional myocardial systolic function in hemodialysis patients with preserved left ventricular ejection fraction and different left ventricular geometry.
    Wang H; Liu J; Yao XD; Li J; Yang Y; Cao TS; Yang B
    Nephrol Dial Transplant; 2012 Dec; 27(12):4422-9. PubMed ID: 22561582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.
    Frank H; Heusser K; Höffken B; Huber P; Schmieder RE; Schobel HP
    Kidney Int; 2004 Aug; 66(2):832-40. PubMed ID: 15253740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure.
    Woodiwiss AJ; Libhaber CD; Majane OH; Libhaber E; Maseko M; Norton GR
    Am J Hypertens; 2008 Oct; 21(10):1144-51. PubMed ID: 18756261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patterns of left ventricular adaptation to arterial hypertension].
    du Cailar G; Ribstein J; Pasquié JL; Macia JC; Halimi JM; Mimran A
    Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1091-3. PubMed ID: 8129506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
    Verma A; Meris A; Skali H; Ghali JK; Arnold JM; Bourgoun M; Velazquez EJ; McMurray JJ; Kober L; Pfeffer MA; Califf RM; Solomon SD
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):582-91. PubMed ID: 19356485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial blood pressure and left ventricular hypertrophy in haemodialysis patients.
    de Lima JJ; Abensur H; Krieger EM; Pileggi F
    J Hypertens; 1996 Aug; 14(8):1019-24. PubMed ID: 8884558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Left ventricular hypertrophy in patient on dialysis].
    Lovcić V; Sebetić D; Klobucić M; Kusec V
    Acta Med Croatica; 2003; 57(1):61-4. PubMed ID: 12876866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertrophy of the left ventricle--etiopathogenesis, clinical consequences and prognosis].
    Ghanem Wisam MA; Murín J; Bulas J
    Vnitr Lek; 1999 Jul; 45(7):421-8. PubMed ID: 11045162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in mediators of left ventricular hypertrophy in dialysis patients.
    Savage T; Giles M; Tomson CV; Raine AE
    Clin Nephrol; 1998 Feb; 49(2):107-12. PubMed ID: 9524781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elderly patients in chronic hemodialysis: risk factors for left ventricular hypertrophy.
    Neves PL; Silva AP; Bernardo I
    Am J Kidney Dis; 1997 Aug; 30(2):224-8. PubMed ID: 9261033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac mortality prevention in uremic patients. Therapeutic strategies with particular attention to complete correction of renal anemia.
    Berweck S; Hennig L; Sternberg C; Dingerkus H; Ludat K; Hampl H
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S80-5. PubMed ID: 10746811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of left ventricular patterns and diastolic dysfunction on hemodialysis patients].
    Gagliardi GM; Rossi S; Manes MT; Gerace G; Martire V; Caruso F; Vocaturo G; De Napoli N
    G Ital Nefrol; 2004; 21(1):45-50. PubMed ID: 15356847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis.
    Chan CT; Floras JS; Miller JA; Richardson RM; Pierratos A
    Kidney Int; 2002 Jun; 61(6):2235-9. PubMed ID: 12028465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
    Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.